Evaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital Environment

Study Overview
=================
Brief Summary
-----------------
Diabetes, obesity and metabolic syndrome are closely linked to sleep apnea syndrome. Indeed, diabetic and/or obese patients present an increased risk of sleep apnoea syndrome (SAS), with a prevalence estimated at between 10 and 22%, depending on the study, and most of them requiring treatment with Continuous Positive Airway Pressure (CPAP). In this sub-population of patients, only between 40% and 50% benefit from CPAP.

Detailed Description
-----------------
There is therefore an under-referral of diabetic patients to treatment, perhaps linked to the way care is organized, which clogs up the circuit and slows down or even prevents access to care. The investigators would like to test a new organization of care to facilitate and intensify this screening.

Official Title
-----------------
Evaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital Environment

Conditions
-----------------
Obese, Sleep Apnea Syndromes, Metabolic Syndrome, Diabetes

Intervention / Treatment
-----------------
* Device: WITHINGS Sleep Analyzer


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients over 18 years old Diabetes Mellitus (Type 1 or 2), or obesity (BMI>30kg/m²) or metabolic syndrome Hospitalized for at least one night in the Endocrinology department Affiliated or entitled to a social security scheme Having received informed information about the study and having co-signed, with the investigator, the informed consent form for participation in the study Exclusion Criteria: Known and/or treated OSAS-type respiratory pathology No signature of the informed consent form Minor or adult patients under guardianship or curatorship

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Screening
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: WITHINGS Sleep Analyzer<br>The sleep apnea screening device used is a medical screening device WITHINGS Sleep Analyzer (WSA) | Device: WITHINGS Sleep Analyzer<br>* Potentially eligible patients will be offered to participate in the study, the information leaflet will be given to them and the informed consent form will be signed if the patient agrees to participate in the study. In hospitalization in Endocrinology: Realization of the current care report Including systematic achievement of EPWORTH and BERLIN scores Activation of the WSA throughout the duration of the hospitalization Completion of a feasibility questionnaire for the team Quantification of the non-usable screening technique Completion of a patient experience questionnaire at the end of the stay In the event of published positive criteria either for the BERLIN questionnaires, EPWORTH questionnaires or WSA, the patient will be referred to the VISAS center for definitive diagnostic evaluation by polygraphy or polysomnography.<br>* Other names: WSA;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| patients real positive for each screening technique | Percentage of patients real positive for each screening technique: BERLIN and EPWORTH score and Withings Sleep Analyzer addressed for polysomnography | Day 2 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of tests | Number of positive tests / Number of analyzable test for screening for each type of test | Day 2 | 
| Patient's experience with the use of Withings Sleep Analyzer | Patients' experience is evaluated using a questionnaire with the following possible answers: yes a lot, yes a little, not at all. | Day 2 | 
| Nurse's satisfaction with the use of Withings Sleep Analyzer | Nurse's satisfaction is evaluated using a questionnaire with the following possible answers: yes a lot, yes a little, not at all. | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Sleep Apnea Syndromes, Diabetes, Withings Sleep analyzer, Epworth, Berlin